Yunxiang Zhu

This inventor holds 22 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Glycoprotein Engineering. Top assignees: Genzyme Corporation, Sanofi. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunxiang Zhu. Retrieved from https://idiyas.com/inventor/yunxiang-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 5)

% Patents Active = 68.2

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 208(Granted Patents)

Location History:

Framingham, MA (US) (2006 - 2010)
Bridgewater, NJ (US) (2016 - 2021)
Wayland, MA (US) (2010 - 2022)
Cambridge, MA (US) (2021 - 2024)

Company Filing History:

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Oligosaccharide

Protein Conjugates

T-cell Activation

Multispecific Binding Molecules

Mannose 6-phosphate

Glycoproteins

Receptor Density Modulation

Lysosomal Storage Disease

Aminooxy Group

Therapeutic Applications

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252504 - Oligosaccharide-protein conjugates (2025-03-18),

2. 12043665 - Inhibitors of T-cell activation (2024-07-23),

3. 11279725 - Oligosaccharide-protein conjugates (2022-03-22),

4. 11254737 - Multispecific binding molecules having specificity to dystroglycan and laminin-2 (2022-02-22),

5. 11028170 - Inhibitors of T-cell activation (2021-06-08),

6. 10973887 - Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof (2021-04-13),

7. 10907142 - Oligosaccharides comprising an aminooxy group and conjugates thereof (2021-02-02),

8. 10626169 - Multispecific binding molecules having specificity to dystroglycan and laminin-2 (2020-04-21),

9. 10464962 - Oligosaccharide-protein conjugates (2019-11-05),

10. 10363291 - Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof (2019-07-30),

11. 9834604 - Inhibitors of T-cell activation (2017-12-05),

12. 9687531 - Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof (2017-06-27),

13. 9493498 - Oligosaccharide-protein conjugates (2016-11-15),

14. 9469850 - Oligosaccharides comprising an aminooxy group and conjugates thereof (2016-10-18),

15. 8841427 - Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof (2014-09-23),

Title: The Innovative Journey of Inventor Yunxiang Zhu

Introduction: Yunxiang Zhu, a talented inventor based in Wayland, MA (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Yunxiang Zhu holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Yunxiang Zhu has had a successful career marked by his ability to turn creative ideas into tangible solutions. His work has not only revolutionized industries but has also improved the lives of many.

Collaborations: Throughout his career, Yunxiang Zhu has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market. His collaborative spirit and dedication to innovation have led to numerous successful projects.

Conclusion: Inventor Yunxiang Zhu's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in his field. His impact on the world of inventions is profound, and his legacy will continue to inspire future generations of inventors.

Profile summary based on public USPTO records.